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Abstract
Background: The heart is rich in cardiolipin, a phospholipid acylated in four sites, predominately
with linoleic acid. Whether or not aging alters the composition of cardiolipin acyl chains is
controversial. We therefore measured the fatty acid concentration of cardiolipin in hearts of 4, 12
and 24 month old rats that consumed one diet, adequate in fatty acids for the duration of their life.
Results: The concentration (nmol/g) of linoleic acid was decreased in 24 month old rats (3965 ±
617, mean ± SD) vs 4 month old rats (5525 ± 656), while the concentrations of arachidonic and
docosahexaenoic acid were increased in 24 month old rats (79 ± 9 vs 178 ± 27 and 104 ± 16 vs
307 ± 68 for arachidonic and docosahexaenoic acids, 4 months vs 24 months, respectively). Similar
changes were not observed in ethanolamine glycerophospholipids or plasma unesterified fatty
acids, suggesting specificity of these effects to cardiolipin.
Conclusion: These results demonstrate that cardiolipin remodeling occurs with aging, specifically




diphosphatidylglycerol) is a phospholipid found in par-
ticularly high concentrations in the heart. In mammalian
cells, it is localized to the inner mitochondrial membrane
[1] and is known for its unique and specific acyl structure.
Cardiolipin, unlike other mammalian phospholipids,
contains 4 stereospecifically numbered acyl groups. Heart
cardiolipin is predominately acylated with linoleic acid
[2]. The acyl specificity of cardiolipin is believed to occur
via remodeling, as the enzymes responsible for its de novo
synthesis are not acyl group specific [3,4].
Despite being discovered a relatively long time ago [5],
fairly little is known about the function of cardiolipin,
especially in mammalian cells. Several excellent reviews
have summarized the known biochemistry and functions
of cardiolipin which is thought to regulate several mito-
chondrial proteins [6-9]. It also is known that cardiolipin
acyl chains vary greatly by species [10-13] and tissue, and
can be modified by diet [14-17]. However, the functional
significance of these changes is not known. It is controver-
sial whether the acyl-chain composition of cardiolipin is
altered with ageing. Several studies have reported that
heart and liver total cardiolipin decreases with age [18-
20]. However, studies measuring the fatty acid composi-
tion (percent composition) of cardiolipin isolated from
aged rat hearts has led to controversial findings, with one
study [19] reporting no change in the acyl percent compo-
sition and another decreased linoleic and increased ara-
chidonic acid percent compositions [20].
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Because of several controversial reports, and of difficulties
in interpreting changes in percent composition (a
decrease in the concentration of one fatty acid increases
the percent composition of other fatty acids), our objec-
tive was to evaluate the absolute fatty acid concentration
of cardiolipin (nmol/g of tissue) in rat heart as a function
of age. By comparing cardiolipin acyl species to those of
another major heart phospholipid (ethanolamine glycer-
ophospholipid), and to plasma unesterified fatty acids,
we are able to determine if any observed effects are spe-
cific to cardiolipin or may be related to substrate availabil-
ity.
Results
Twenty four and 12 month old rats weighed significantly
more than 4 month old rats (396 ± 13, 415 ± 30 and 291
± 20 grams, for 24, 12 and 4 month old rats, respectively
p < 0.01). As well, hearts from 24 and 12 month old rats
weighed significantly more than hearts from 4 month old
rats (0.91 ± .08, 0.92 ± 0.07 and 0.75 ± 0.06 grams for 24,
12 and 4 month old rats, respectively p < 0.01).
The concentration of linoleic acid was significantly lower
(28 %) in the heart of 24 month-old rats compared to 4
month old rats (p < 0.01), while the concentrations of pal-
mitic, arachidonic and docosahexaenoic acids were
increased 46 % (p < 0.05), 99 % (p < 0.001) and 195 %
(p < 0.001), respectively (Table 1). The concentrations of
arachidonic and docosahexaenoic acids were also signifi-
cantly higher in cardiolipin 12 month old rat hearts, com-
pared to 4 month old rat hearts. Ethanolamine
glycerophospholipid linoleic acid concentrations of were
56% lower in hearts of 24 month-old rats compared
hearts of 4 month-old rats (p < 0.001). There was no sig-
nificant difference in other fatty acids within eth-
anolamine glycerophospholipids between 24 month and
4 month-old rat hearts. The concentration of plasma
unesterified stearic acid was significantly lower in 24
month, compared to 4 month old rats (Table 2), but there
was no other significant difference in any measured
plasma unesterified plasma fatty acids concentration.
Discussion
Heart fatty acid concentrations in the current study agree
with those previously published[21,22]. The total concen-
tration of cardiolipin has been shown to decrease with age
in human epidermal cells [13], and in the liver [19] and
heart of the rat [18,20]. However, it is controversial as to
whether or not heart cardiolipin is also remodeled
(changes its acyl composition) with age. One study
reported that aging increased the percent composition of
arachidonic acid, while another reported no change in
percent composition [18,20]. Assessing fatty acid changes
in terms of percent composition is difficult, as a decrease
or increase in the concentration of one has the opposite
effect on the percent composition of other fatty acids.
Here we show for the first time that the absolute concen-
tration of linoleic acid decreases in cardiolipin of the aged
rat heart, while although quantitatively less, the absolute
concentration of arachidonic and docosahexaenoic acids
Table 1: Concentration of selected fatty acids in cardiolipin and ethanolamine glycerophospholipids of 4, 12 and 24 month old rat 
hearts
Cardiolipin Ethanolamine Glycerophospholipids
Fatty Acid 4 Months 12 Months 24 Months 4 Months 12 Months 24 Months
Palmitic acid (16:0) 44 ± 7a 62 ± 15 64 ± 15 * 1166 ± 150 1426 ± 297 1135 ± 129
Stearic acid (18:0) 47 ± 4 49 ± 10 47 ± 14 3943 ± 327 4068 ± 806 3295 ± 373
Oleic acid (18:1n-9) 279 ± 42 291 ± 53 347 ± 57 394 ± 46 372 ± 88 349 ± 30
Linoleic acid (18:2n-6) 5525 ± 656 6025 ± 1094 3965 ± 617 ** 1032 ± 168 864 ± 158 * 459 ± 129 ***
Arachidonic acid (20:4n-6) 79 ± 9 140 ± 54 * 178 ± 27 *** 2625 ± 155 2662 ± 595 2346 ± 260
Docosahexaenoic acid (22:6n-3) 104 ± 16 230 ± 95 * 307 ± 68 *** 3511 ± 279 4436 ± 899 * 3576 ± 326
Σ Of major fatty acids 8374 ± 650 8652 ± 1278 7107 ± 845 * 12672 ± 1032 132829 ± 2796 11161 ± 1002
a Data are mean ± SD, n = 6 samples per group, nmol/g wet weight *, p < 0.05, **p < 0.01, ***p < 0.001 vs 4 Months.
Table 2: Plasma concentration of major unesterified fatty acids in 4, 12 and 24 month old rats
Fatty Acid 4 Months (nmol/ml) 12 Months (nmol/ml) 24 Months (nmol/ml)
Palmitic acid (16:0) 450 ± 85 396 ± 142 293 ± 162
Stearic acid (18:0) 130 ± 17 112 ± 26 86 ± 23 *
Oleic acid (18:1n-9) 281 ± 75 291 ± 156 226 ± 148
Linoleic acid (18:2n-6) 366 ± 94 397 ± 231 254 ± 135
Arachidonic acid (20:4n-6) 69 ± 16 73 ± 33 56 ± 18
Docosahexaenoic acid (22:6n-3) 20 ± 7 21 ± 10 16 ± 7
Data are mean ± SD n = 6 per group. * p < 0.05 vs 4 MonthsLipids in Health and Disease 2006, 5:2 http://www.lipidworld.com/content/5/1/2
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increases. In the current study, total fatty acids in eth-
anolamine glycerophospholipids did not change and this
is broadly consistent with several other studies reporting
no change in heart ethanolamine glycerophospholipids
with age [10,19,20]. Because the amount of cardiolipin
was shown to decrease with age, it was not surprising to
find a decrease in total fatty acid and linoleic acid concen-
trations. However, our finding that arachidonic acid and
docosahexaenoic acid concentrations increased supports
the hypothesis that cardiolipin remodeling occurs with
ageing. More specifically, this remodeling increases die-
tary essential highly unsaturated fatty acids [20]. Increased
concentrations of arachidonic and docosahexaenoic acid
were not observed in the ethanolamine glycerophosphol-
ipid class, and thus unlikely reflect their availability. The
changes most likely represent changes in cardiolipin
acylation/deacylation in heart. Further supporting this
idea is that there was no difference in the plasma unester-
ified fatty acid concentrations of linoleic, arachidonic and
docosahexaenoic acid, the major source of heart fatty
acids [23]. Increased arachidonic and docosahexaenoic
acids in cardiolipin of the aged heart may help to main-
tain a high unsaturation index in the presence of
decreased linoleic acid [20].
The implications of cardiolipin remodeling with age are
not known. In patients with systemic lupus erythemato-
sus, cardiolipin acyl groups are believed to form epitopes
with antiphospholipid antibodies, and it has been shown
that linolenic acid acyl groups have the highest affinity for
antiphospholipid antibodies [24]. Thus cardiolipin
remodeling with aging may alter cardiolipin's binding to
antiphospholipid antibodies, altering the autoimmune
response in conditions such as systemic lupus erythema-
tosus. Increased lipid peroxidation is a plausible mecha-
nism by which cardiolipin levels decrease with age.
Therefore, increasing the unsaturation of the acyl-side
chains would be expected to increase their susceptibility
to peroxidation [25]. Furthermore, cardiolipin remode-
ling can alter the oxygen consumption by the heart and
the remodeling observed with aging may contribute to
this process [9].
Conclusion
In summary, our results show that cardiolipin remodeling
does occur with aging and specifically that the increased
concentrations of the nutritionally essential highly
unsaturated fatty acids, arachidonic and docosahexaenoic
are specific to rat heart cardiolipin as it does not occur in
ethanolamine glycerophospholipids. Although several
models (dietary, aging) have shown that remodeling of




The study was conducted following the National Institutes
of Health Guidelines for the Care and Use of Laboratory
Animals (Publication no. 80-23), and was approved by
the National Institutes of Child Health and Development
Animal Care and Use Committee. Male CDF-344 rats, 4,
12 and 24 months of age were obtained from the National
Institutes on Aging colony (Baltimore, MD). The rats were
acclimatized for 1 week in an animal facility in which
temperature, humidity and light cycle were controlled,
and had ad libitum access to food (NIH-31) from weaning
until the completion of the study. The NIH-31 diet con-
tains 20.1 % total saturates, 22.5 % total monounsatu-
rates, 47. 9 % linoleic acid, 5.1% α-linolenic acid, 0.02%
arachidonic acid and 2.3 % docosahexaenoic acid (see
lipid extraction and chromatography section for diet anal-
ysis). This diet is adequate in both omega 3 and 6 fatty
acids [26].
Rats were removed from food and water for approxi-
mately one hour before being anesthetized with sodium
pentobarbital and decapitated. We previously showed
that microwave fixation is not required to determine the
phospholipid concentration of the rat heart [22]. A blood
sample was collected from the decapitated animal and the
heart was quickly removed, rinsed in ice-cold saline and
frozen at -80°C.
Lipid extraction and chromatography
Total lipids were extracted from diet, plasma and heart
according the method of Folch [27]. Heptadecaenoic acid
(17:0) was added as an internal standard to plasma prior
to extraction. The extracts were separated by thin layer
chromatography on silica gel plates (Whatman, Clifton,
NJ). Ethanolamine glycerophospholipid was separated in
chloroform: methanol: H2O: glacial acetic acid (60:50:4:1
by volume) [28] and identified with unlabeled standards
in separate lanes. Cardiolipin was separated using acetone
and petroleum ether (1:3 by volume). The plate was
removed, briefly allowed to dry and rerun using chloro-
form, methanol and glacial acetic acid (80:13:0.3 by vol-
ume), and identified with unlabeled standards in separate
lanes. Lipid classes and standard bands were visualized
with 6-p-toluidine-2-naphthalene-sulfonic acid (Acros,
Fairlawn, NJ) under ultraviolet light. Bands were individ-
ually scraped and 200 µl toluene was added with a known
amount of di-17:0-PC for quantification prior to methyl-
ation. Fatty acid methyl esters were formed by heating the
phospholipid scrapes and a portion of the diet total lipid
extract in 1% H2SO4 in methanol at 70°C for 3 hours [29].
The methyl esters were separated on a 30 m × 0.25 mm i.d.
capillary column (SP-2330, Supelco; Bellefonte, PA),
using gas chromatography with a flame ionization detec-
tor (Model 6890N, Agilent Technologies; Palo Alto, CA,Lipids in Health and Disease 2006, 5:2 http://www.lipidworld.com/content/5/1/2
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USA). Runs were initiated at 80°C, with a temperature
gradient to 160°C (10°C/min) and 230°C (3°C/min) in
31 min, and held at 230°C for 10 min. Peaks were identi-
fied by retention times of fatty acid methyl ester standards
(Nu-Chek-Prep, Elysian, MN). Fatty acid concentrations
(nmol/g brain or nmol/ml plasma) were calculated by
proportional comparison of gas chromatography peak
areas to that of the 17:0 internal standard.
Data and statistics
Data are presented as means ± SD, n = 6 samples per
group. One-way ANOVA with Dunnett's post hoc test,
comparing 24 and 12 month means to 4 month means
was completed using SAS 9.0 (Cary, NC). Statistical signif-
icance was taken as p ≤ 0.05.
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